Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Thompson Street Capital Partners has agreed to acquire Vector Laboratories for $124mm
Abcam has agreed to acquire BioVision for approximately $340mm
Nanox has agreed to acquire Zebra Medical Vision for $200mm